Pharma
Why experts project a boom in healthcare M&A activity in 2025
Factors like lower inflation and interest rate cuts make 2025 a good year for getting deals done.
Factors like lower inflation and interest rate cuts make 2025 a good year for getting deals done.
Pharma companies have warned that the lowered prices will mean less drug innovation.
AI saves time, but can it save billions?
Total investment dollars more than tripled between 2023 and 2024, according to an SVB analysis.
This month saw a bankruptcy at Prospect Medical Holdings and an HCA acquisition.
United Healthcare Workers East discussed workplace changes following Optum and Summit Health acquisitions.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.